Prescott’s Microbiology, 9th Edition 37 Epidemiology and Public Health Microbiology CHAPTER OVERVIEW This chapter discusses the epidemiological parameters used to institute effective control, prevention, and eradication measures within an affected or potentially affected population, including a discussion of vaccines and immunization procedures. It also discusses the epidemiology of hospital-acquired (nosocomial) infections and bioterrorism, which have been of increasing concern in recent years. LEARNING OUTCOMES After reading this chapter you should be able to: define the agencies that are responsible for disease prevention and control define the basic vocabulary and processes used in the science of epidemiology evaluate the effectiveness of public health surveillance methods deduce the impact of public health methods on the quality of U.S. life over the last 100 years describe the use of geographical information systems to track diseases remotely use standardized surveillance data to measure infectious disease frequency calculate rates of incidence, prevalence, morbidity, and mortality discriminate between a communicable and a noncommunicable disease interpret population infection data to define epidemic and pandemic events apply the concept of herd immunity to public health in your community predict potential infectious disease outbreaks from molecular data revealing antigenic drift and antigenic shift events report on recently emerged and reemerging global infectious diseases organize geographic data to reveal changes in microbial drug resistance and vector spread of infection report the major causes of health-care-associated infection in the United States distinguish community-acquired pathogens from health-care–associated pathogens, and explain why community-acquired pathogens are of concern to hospital personnel recommend measures for preventing and controlling health-care–-associated infections assemble communicable disease linkages to create a chain of infection reveal the weakest link in the chain of infection advise vaccine use to prevent infectious disease transmission in a population explain the role of disinfection, sanitation, and chemotherapy to control infectious disease transmission in a population discuss the readiness efforts necessary to be prepared for a bioterrorism attack prioritize microorganisms based on public health threat construct tables of prevention and control information relative to an infectious agent alert appropriate authorities in response to suspected acts of bioterrorism CHAPTER OUTLINE I. Epidemiology 1 © 2014 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in any manner. This document may not be copied, scanned, duplicated, forwarded, distributed, or posted on a website, in whole or part. Prescott’s Microbiology, 9th Edition A. Epidemiology—the science that evaluates the occurrence, determinants, distribution, and control of health and disease in a defined human population B. Epidemiologist—one who practices epidemiology (a disease detective) 1. Centers for disease control (CDC) US agency of epidemiologists 2. World health organization – worldwide counterpart to the CDC 3. John Snow – British physician – first epidemiologist C. Epidemiologists use a variety of terms to describe different types of disease occurrence 1. Sporadic disease—occurs occasionally at irregular intervals in a human population 2. Endemic disease—maintains a relatively steady, low-level frequency at a moderately regular interval 3. Hyperendemic disease—a gradual increase in frequency above the endemic level, but not to the epidemic level 4. Outbreak—an epidemic-like increase in frequency, but in a very limited (focal) segment of the population 5. Epidemic—sudden increase in frequency above the endemic level 6. Index case—the first case in an epidemic 7. Pandemic—a long-term increase in frequency in a large (usually worldwide) population II. Epidemiological Methods A. Public health surveillance 1. Proactive evaluation of genetic background, environmental conditions, human behaviors, and lifestyle choices, emerging infectious agents, and microbial responses to chemotherapeutic agents 2. Data is gathered by population surveys (sentinel surveillance) and case reporting (retrospective comparisons) B. Remote sensing and geographic information systems: charting infectious disease data 1. Map-based tools that can be used to study the distribution, dynamics, and environmental correlates of microbial disease 2. Remote sensing—gathering digital images of Earth’s surfaces from satellites and transforming data to maps 3. Geographic information system (GIS)—data management system 4. This approach works best with diseases clearly associated with mapped environmental variables (e.g., vegetation types, elevation, precipitation) III. Measuring Infectious Disease Frequency A. Measures of frequency are usually expressed as fractions; the numerator equals the number of individuals experiencing the event; the denominator is the number of individuals in whom event could have occurred B. Statistics—the mathematics of collection, organization, and interpretation of numerical data C. Cases of certain diseases must be reported to public health agencies, so-called "reportable diseases" D. Morbidity rate—the number of new cases in a specific time period per unit of population E. Prevalence rate—number of individuals infected at any one time per unit of population F. Mortality rate—number of deaths from a disease per number of cases of the disease IV. Patterns of an Infectious Disease in a Population A. Infectious disease is a disease resulting from infection by microbial agents; a communicable disease is an infectious disease that can be transmitted from person to person B. Two types of epidemics 1. Common-source epidemic—characterized by a sharp rise to a peak and then a rapid but not as pronounced decline in the number of cases; usually results from exposure of all infected individuals to a single, common contaminated source, such as food or water 2. Propagated epidemic—characterized by a gradual increase and then a gradual decline in the number of cases; usually results from the introduction of one infected individual into a population, who then infects others; these in turn infect more, until an unusually large number of individuals within the population are infected C. Recognition of an epidemic involves various surveillance methods to monitor the population for disease occurrence and for demographic analysis 2 © 2014 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in any manner. This document may not be copied, scanned, duplicated, forwarded, distributed, or posted on a website, in whole or part. Prescott’s Microbiology, 9th Edition D. Herd immunity—the resistance of a population to infection and to the spread of an infectious organism due to the immunity of a large percentage of the population; this limits the effective contact between infective and susceptible individuals E. Antigenic shift—genetically determined changes in the antigenic character of a pathogen so that it is no longer recognized by the host's immune system (e.g., new flu strains); smaller changes are called antigenic drift; can lead to increases in disease frequency because the population of susceptible hosts increases V. Emerging and Reemerging Infectious Diseases and Pathogens A. New diseases have emerged in the past few decades (e.g., AIDS, hantavirus pulmonary syndrome, and many “old” diseases that have increased in frequency, such as tuberculosis) B. The Centers for Disease Control (CDC) has defined such diseases as “new, reemerging, or drugresistant infections whose incidence has increased in the last two decades or whose incidence threatens to increase in the near future”; these diseases are the focus of systematic epidemiology, which is concerned with the ecological and social factors that influence the development and emergence of disease C. Reasons for increases in emerging and reemerging infectious diseases 1. Economic and military forces can cause population shifts and disruptions of normal public health measures 2. Changes in sexual behavior, use of IV drugs, and changes in food preferences affect disease transmission 3. Increasing population density a. Overcrowding increases possibility of exposure b. Sanitary measures and health-care systems can become overburdened c. Encroachment and destruction of natural habitats exposes humans to new pathogens d. Introduction of pathogens into new environments can alter transmission and exposure patterns 4. Global climate change affects microbial selection and survival in the environment 5. Drug resistance has increased dramatically in nosocomial pathogens due to excessive or inappropriate use of antimicrobial therapy 6. Rapid transportation systems aid in the spread of disease out of areas where they are endemic VI. Health-Care–Associated Infections A. Produced by infectious agents that develop within a hospital or other clinical care facility and that are acquired by patients while they are in the facility; infections that are incubating within the patient at the time of admission are not considered nosocomial; methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) are particularly troublesome. Often referred to as nosocomial infections B. Source 1. Endogenous—patient's own microbiota 2. Exogenous—microbiota other than the patient's 3. Autogenous—cannot be determined to be endogenous or exogenous C. Control, prevention, and surveillance—should include proper handling of the patient and the materials provided to the patient, as well as monitoring of the patient for signs of infection and prudently using antibiotics D. The hospital epidemiologist—an individual (usually a registered nurse) responsible for developing and implementing policies to monitor and control infections and communicable disease; usually reports to an infection control committee or other similar group VI. Prevention and Control of Epidemics A. Reduce or eliminate the source or reservoir of infection through: 1. Quarantine and isolation of cases and carriers 2. Destruction of an animal reservoir, if one exists 3. Treatment of sewage to reduce contamination of water 4. Therapy that reduces or eliminates infectivity of individuals B. Break the connection between the source and susceptible individuals through sanitization, disinfection, vector control, and other measures; examples include: 1. Chlorination of water supplies 2. Pasteurization of milk 3 © 2014 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in any manner. This document may not be copied, scanned, duplicated, forwarded, distributed, or posted on a website, in whole or part. Prescott’s Microbiology, 9th Edition 3. Supervision and inspection of food and food handlers 4. Destruction of insect vectors with pesticides C. Reduce the number of susceptible individuals—increase herd immunity 1. Passive immunization to give temporary immunity following exposure 2. Active immunization to protect individuals and host population D. Vaccines and immunization 1. Vaccine—a preparation containing one or more antigens of a pathogen; immunization results from the immunity stimulated by the delivery of vaccines; vaccinomics is the application of genomics and bioinformatics to vaccine development 2. More efficient immune responses are obtained by mixing antigens with adjuvants, nontoxic materials that help to stimulate a strong immune response 3. Vaccines and vaccination have a long history starting with Jenner’s use of cowpox as a vaccine against smallpox; today there are many vaccines, and vaccination is one of the most costeffective methods for preventing microbial disease 4. Immunization practices depend on the age of the individual and the risk group to which the individual belongs a. Children begin a vaccination series at 2 months of age; the series protects against numerous childhood disease (e.g., measles, mumps, rubella) b. Adults living in close quarters, having reduced immunity, traveling in other countries, and working in certain professions (e.g., health care provider) may receive additional immunizations E. Types of vaccines and their characteristics 1. Whole-cell vaccines a. Consist of whole organisms that have been inactivated (killed) or attenuated (live but avirulent); in general, attenuated whole-organism vaccines are most effective and easy to use, and they provide more complete immunity b. Though considered the “gold-standard,” numerous problems are associated with wholecell vaccines 1) Fail to shield against some diseases 2) Attenuated vaccines can cause disease in immunocompromised individuals 3) Attenuated viruses can revert to virulence 2. Acellular or subunit vaccines—vaccines containing specific, purified macromolecules derived from pathogen (capsular polysaccharides, recombinant surface antigens, and inactivated exotoxins called toxoids); avoid many of common risks associated with whole-cell vaccines 3. Recombinant-vector vaccines—vaccines containing genetically engineered viruses or bacteria, having genes that encode major antigens from a pathogen; elicit both humoral and cellular immunity 4. DNA vaccines—vaccines containing recombinant DNA molecules (usually a plasmid); the DNA is taken up by muscle cells after injection and enters host nuclei; the antigen gene is then expressed, producing antigenic proteins that elicit both humoral and cellular immunity; currently several human trials of DNA vaccines are underway F. Role of the public health system: epidemiological guardian—a network of health professionals involved in surveillance, diagnosis, and control of epidemics (e.g., The Centers for Disease Control and Prevention and the World Health Organization) VII. Bioterrorism Preparedness A. Bioterrorism is the intentional or threatened use of microorganisms or toxins from living organisms to produce death or disease in humans, animals, and plants B. The list of biological agents that could pose the greatest public health risk is short, and includes viruses, bacteria, parasites, and toxins C. Indicators of a bioterrorism attack include a sudden increase in cases of an unusual disease in humans or animals D. Biological weapons are more destructive than chemical weapons; the United States government recently launched an initiative to create a biological weapons defense; global organizations also are working to detect and respond to bioterrorist attacks 4 © 2014 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in any manner. This document may not be copied, scanned, duplicated, forwarded, distributed, or posted on a website, in whole or part. Prescott’s Microbiology, 9th Edition CRITICAL THINKING 1. Explain the concept of herd immunity. How can it develop naturally? How can it be stimulated artificially? Cite examples of both methods. 2. Explain antigenic drift and how it overcomes herd immunity and leads to new outbreaks of the same disease. 3. The authors present a number of surveillance methods used by epidemiologists. Discuss these methods in the context of a particular disease of past or current importance (e.g., smallpox, AIDS) to show how the data collected by these methods increase our knowledge of the disease process. 4. Over the last 100 years there have been very successful campaigns against infectious diseases such as poliomyelitis, leprosy, and tuberculosis. There have also been some works in progress such as HIV, malaria, and drug resistant tuberculosis. How has understanding the chain of infection concept perpetuated the success of efforts to curtail these pathogens. CONCEPT MAPPING CHALLENGE Map the following concepts to demonstrate your understanding of their relatedness. Bioterrorism Population Immunity Vector Incidence Vehicle Infectious disease Zoonosis Mortality Morbidity Epidemiology Communicable Statistics Vaccine WHO CDC 5 © 2014 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in any manner. This document may not be copied, scanned, duplicated, forwarded, distributed, or posted on a website, in whole or part.